View in EDS HTML Full Text PDF Full Text

Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report.

Saved in:
Bibliographic Details
Title: Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report.
Authors: Yuen CA; Department of Neurology, Division of Neuro-oncology, University of California, Irvine, Irvine, CA, United States.; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States., Jafarvand M; Department of Radiology, Division of Nuclear Medicine, University of California, Irvine, Irvine, CA, United States., Kamson DO; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, United States.; Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD, United States., Chu E; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States.; Department of Radiology, Division of Neuroradiology, University of California, Irvine, Irvine, CA, United States., Soun JE; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States.; Department of Radiology, Division of Neuroradiology, University of California, Irvine, Irvine, CA, United States., Yong WH; Department of Pathology, Division of Neuropathology, University of California, Irvine, Irvine, CA, United States., Hsu FP; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States.; Department of Neurosurgery, University of California, Irvine, Irvine, CA, United States., Bow H; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States.; Department of Neurosurgery, University of California, Irvine, Irvine, CA, United States., Zheng M; UC Irvine Charlie Dunlop School of Biological Sciences, Irvine, Irvine, CA, United States., Srinivas SM; Department of Radiology, Division of Nuclear Medicine, University of California, Irvine, Irvine, CA, United States.
Source: Frontiers in oncology [Front Oncol] 2026 Jun 11; Vol. 16, pp. 1820428. Date of Electronic Publication: 2026 Jun 11 (Print Publication: 2026).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42370133
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combined SSTR2-targeted Analogue with <superscript>177</superscript>Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yuen+CA%22">Yuen CA</searchLink>; Department of Neurology, Division of Neuro-oncology, University of California, Irvine, Irvine, CA, United States.; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States.<br /><searchLink fieldCode="AU" term="%22Jafarvand+M%22">Jafarvand M</searchLink>; Department of Radiology, Division of Nuclear Medicine, University of California, Irvine, Irvine, CA, United States.<br /><searchLink fieldCode="AU" term="%22Kamson+DO%22">Kamson DO</searchLink>; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, United States.; Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD, United States.<br /><searchLink fieldCode="AU" term="%22Chu+E%22">Chu E</searchLink>; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States.; Department of Radiology, Division of Neuroradiology, University of California, Irvine, Irvine, CA, United States.<br /><searchLink fieldCode="AU" term="%22Soun+JE%22">Soun JE</searchLink>; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States.; Department of Radiology, Division of Neuroradiology, University of California, Irvine, Irvine, CA, United States.<br /><searchLink fieldCode="AU" term="%22Yong+WH%22">Yong WH</searchLink>; Department of Pathology, Division of Neuropathology, University of California, Irvine, Irvine, CA, United States.<br /><searchLink fieldCode="AU" term="%22Hsu+FP%22">Hsu FP</searchLink>; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States.; Department of Neurosurgery, University of California, Irvine, Irvine, CA, United States.<br /><searchLink fieldCode="AU" term="%22Bow+H%22">Bow H</searchLink>; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, United States.; Department of Neurosurgery, University of California, Irvine, Irvine, CA, United States.<br /><searchLink fieldCode="AU" term="%22Zheng+M%22">Zheng M</searchLink>; UC Irvine Charlie Dunlop School of Biological Sciences, Irvine, Irvine, CA, United States.<br /><searchLink fieldCode="AU" term="%22Srinivas+SM%22">Srinivas SM</searchLink>; Department of Radiology, Division of Nuclear Medicine, University of California, Irvine, Irvine, CA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Jun 11; Vol. 16, pp. 1820428. <i>Date of Electronic Publication: </i>2026 Jun 11 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42370133
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2026.1820428
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1820428
    Titles:
      – TitleFull: Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yuen CA
      – PersonEntity:
          Name:
            NameFull: Jafarvand M
      – PersonEntity:
          Name:
            NameFull: Kamson DO
      – PersonEntity:
          Name:
            NameFull: Chu E
      – PersonEntity:
          Name:
            NameFull: Soun JE
      – PersonEntity:
          Name:
            NameFull: Yong WH
      – PersonEntity:
          Name:
            NameFull: Hsu FP
      – PersonEntity:
          Name:
            NameFull: Bow H
      – PersonEntity:
          Name:
            NameFull: Zheng M
      – PersonEntity:
          Name:
            NameFull: Srinivas SM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 06
              Text: 2026 Jun 11
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1